web design

The Major Medical Impact of Federal Reclassification

Federal Reclassification of Marijuana Could Have Major Impact on Medical Uses

Federal authorities have announced that they are reviewing the possibility of loosening the classification of marijuana, and if this happens, it could have a far-reaching impact on how the substance is used in medical settings, experts said.

Medical experts are welcoming the review, saying it could ease restrictions for researchers, so that they can better understand which compounds in marijuana could be used to help patients.

The American Medical Association told ABC News that the group supports the review "to help facilitate scientific research and the development of cannabinoid-based medicines."

Steph Sherer, the founder of the medical marijuana advocacy group Americans for Safe Access, said changing the classification could be a "paradigm change." She pointed out there is currently only one..(Read more)

DEA To Decide Whether To Reschedule Pot By Mid-Year

The DEA will decide whether to change course on marijuana by July. Memo also underscores how little marijuana is being made available for research purposes

In a lengthy memo to lawmakers, the Drug Enforcement Administration said it hopes to decide whether to change the federal status of marijuana "in the first half of 2016."

Marijuana is currently listed under the Controlled Substances Act as aSchedule 1 drug, meaning that for the purposes of federal law, the drug has "no medical use and a high potential for abuse" and is one of "the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence." Marijuana shares Schedule 1 status with heroin, and it is more strictly regulated than the powerful prescription painkillers that have killed more than 165,000 people since 1999